Personal information

Tumor Immunology, Cancer Immunotherapy
Taiwan

Activities

Employment (3)

National Cancer Institute: Bethesda, MD, US

2022-02-28 to present | Visiting Fellow (Developmental Therapeutics Branch)
Employment
Source: Self-asserted source
Nai-Yun Sun

Johns Hopkins University: Baltimore, Maryland, US

2021-03-01 to 2022-02-27 | Postdoc Fellow (Pathology)
Employment
Source: Self-asserted source
Nai-Yun Sun

National Yang Ming Chiao Tung University: Taipei, TW

2019-08 to 2021-02 | Postdoc Fellow (Institute of Clinical Medicine)
Employment
Source: Self-asserted source
Nai-Yun Sun

Education and qualifications (1)

National Taiwan University: Taipei, TW

2012-09 to 2019-06 | Ph.D. (Graduate Institute of Oncology)
Education
Source: Self-asserted source
Nai-Yun Sun

Works (45)

Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

Cancer Research Communications
2024-03-19 | Journal article
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

Data from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

Data from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

FIGURE 1 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

FIGURE 1 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

FIGURE 2 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

FIGURE 2 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

FIGURE 3 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

FIGURE 3 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

FIGURE 4 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

FIGURE 4 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

FIGURE 5 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

FIGURE 5 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

FIGURE 6 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

FIGURE 6 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

FIGURE 7 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

FIGURE 7 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

FIGURE 8 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

FIGURE 8 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

Supplementary Figure S1 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

Supplementary Figure S1 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

Supplementary Figure S2 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

Supplementary Figure S2 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

Supplementary Figure S3 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

Supplementary Figure S3 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

Supplementary Figure S4 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

Supplementary Figure S4 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

Supplementary Figure S5 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

Supplementary Figure S5 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

Supplementary Figure S6 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

Supplementary Figure S6 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

Supplementary Table S1 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

Supplementary Table S1 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

Supplementary Table S2 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

Supplementary Table S2 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

Supplementary Table S3 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

Supplementary Table S3 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts

2024-03-19 | Preprint
Contributors: Yasuhiro Arakawa; Ukhyun Jo; Suresh Kumar; Nai-Yun Sun; Fathi Elloumi; Anish Thomas; Nitin Roper; Diana Grace Varghese; Naoko Takebe; Xiaohu Zhang et al.
Source: check_circle
Crossref

Preclinical Models of Adrenocortical Cancer.

Cancers
2023-05-23 | Journal article
Contributors: Andrew Jacob Herse Sedlack; Samual Hatfield; Kumar S; Arakawa Y; Nitin Roper; Sun NY; Nilubol N; Kiseljak-Vassiliades K; Hoang CD; Bergsland EK et al.
Source: Self-asserted source
Nai-Yun Sun

Eg5 as a Prognostic Biomarker and Potential Therapeutic Target for Hepatocellular Carcinoma

Cells
2021-07-05 | Journal article
Part of ISSN: 2073-4409
Source: Self-asserted source
Nai-Yun Sun

Metabolic Reprogramming and Epithelial-Mesenchymal Plasticity: Opportunities and Challenges for Cancer Therapy

Frontiers in Oncology
2020-05-20 | Journal article
Part of ISSN: 2234-943X
Source: Self-asserted source
Nai-Yun Sun

Blockade of PD-L1 Enhances Cancer Immunotherapy by Regulating Dendritic Cell Maturation and Macrophage Polarization

Cancers
2019-09-19 | Journal article
Contributors: Nai-Yun Sun; Yu-Li Chen; Wen-Yih Wu; Han-Wei Lin; Ying-Cheng Chiang; Chi-Fang Chang; Yi-Jou Tai; Heng-Cheng Hsu; Chi-An Chen; Wei-Zen Sun et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

mTOR Inhibitors Can Enhance the Anti-Tumor Effects of DNA Vaccines through Modulating Dendritic Cell Function in the Tumor Microenvironment

Cancers
2019-05-02 | Journal article
Part of ISSN: 2072-6694
Contributors: Yu-Li Chen; Han-Wei Lin; Nai-Yun Sun; Jr-Chi Yie; Hsueh-Chih Hung; Chi-An Chen; Wei-Zen Sun; Wen-Fang Cheng
Source: Self-asserted source
Nai-Yun Sun via Crossref Metadata Search

Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes

Cancer Letters
2019-03 | Journal article
Part of ISSN: 0304-3835
Contributors: Nai-Yun Sun; Yu-Li Chen; Han-Wei Lin; Ying-Cheng Chiang; Chi-Fang Chang; Yi-Jou Tai; Chi-An Chen; Wei-Zen Sun; Chung-Liang Chien; Wen-Fang Cheng
Source: Self-asserted source
Nai-Yun Sun via Crossref Metadata Search

CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells

Endocrine-Related Cancer
2019-01 | Journal article
Part of ISSN: 1351-0088
Contributors: Han-Wei Lin; Ying-Cheng Chiang; Nai-Yun Sun; Yu-Li Chen; Chi-Fang Chang; Yi-Jou Tai; Chi-An Chen; Wen-Fang Cheng
Source: Self-asserted source
Nai-Yun Sun via Crossref Metadata Search

Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation

Cancer Letters
2018-07 | Journal article
Part of ISSN: 0304-3835
Contributors: Yu-Li Chen; Ming-Cheng Chang; Ying-Cheng Chiang; Han-Wei Lin; Nai-Yun Sun; Chi-An Chen; Wei-Zen Sun; Wen-Fang Cheng
Source: Self-asserted source
Nai-Yun Sun via Crossref Metadata Search

Peer review (1 review for 1 publication/grant)

Review activity for Cancers. (1)